Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.70 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.63 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.61 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 5/20 | 0.55 |
| ▸ | ACHE | P22303 | 4/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2990657 | 1.00 | MAOB (0.70) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL2990656 | 1.00 | MAOB (0.70) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL2995394 | 1.00 | MAOB (0.70) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL3003873 | 0.97 | MAOB (0.70) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL3001785 | 0.97 | MAOB (0.70) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL3001789 | 0.97 | MAOB (0.70) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL3003871 | 0.97 | MAOB (0.70) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL3003821 | 0.96 | MAOB (0.68) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL2990701 | 0.96 | MAOB (0.68) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 | |
| SCHEMBL3003819 | 0.96 | MAOB (0.68) | MAOBTNFRSF1AABCG2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119954731-A | Chalcone derivative containing 4-quinazolinone structure, and preparation method and application thereof | 黔南州烟草公司平塘县分公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-117645567-A | Chalcone derivative containing piperidine sulfonamide structure, and preparation method and application thereof | 贵州大学 | 2024-03-05 | — | — | CN | disclosed |
| US-7787085-B2 | Optical alignment method and liquid crystal display element | JSR CORPORATION (JP) | 2010-08-31 | — | — | US | disclosed |
| US-20080123046-A1 | OPTICAL ALIGNMENT METHOD AND LIQUID CRYSTAL DISPLAY ELEMENT | JSR CORPORATION (JP) | 2008-05-29 | — | — | US | disclosed |
| EP-1336636-B1 | Liquid crystal aligning agent,method of forming a liquid crystal alignment film and liquid crystal display element | JSR CORP (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-20050259203-A1 | Optical alignment method and liquid crystal display element | JSR CORPORATION (JP) | 2005-11-24 | — | — | US | disclosed |
| US-6887534-B2 | Liquid crystal aligning agent, method of forming a liquid crystal alignment film and liquid crystal display element | JSR CORPORATION (JP) | 2005-05-03 | — | — | US | disclosed |
| US-20040009310-A1 | Liquid crystal aligning agent, method of forming a liquid crystal alignment film and liquid crystal display element | JSR CORPORATION (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1353217-A1 | Optical alignment method and liquid crystal display element | JSR Corporation (JP) | 2003-10-15 | — | — | EP | disclosed |
| EP-1336636-A1 | Liquid crystal aligning agent,method of forming a liquid crystal alignment film and liquid crystal display element | JSR Corporation (JP) | 2003-08-20 | — | — | EP | disclosed |